Display options
Share it on

J Thromb Thrombolysis. 1997;4(3):345-347. doi: 10.1023/a:1008841215025.

Low-Molecular-Weight Heparin in the Initial Treatment of Proximal Deep Vein Thrombosis.

Journal of thrombosis and thrombolysis

Valentine, Pineo, Hull

Affiliations

  1. Clinical Trials Unit, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.

PMID: 10639639 DOI: 10.1023/a:1008841215025

Abstract

Intravenous unfractionated heparin followed by oral warfarin is the current standard of care for the treatment of acute venous thrombosis. More recently, several low-molecular-weight heparin preparations have been shown to be as effective and safe as unfractionated heparin for the initial therapy of acute proximal vein thrombosis. These drugs have a number of advantages over unfractionated heparin, and will undoubtedly replace the current standard for the initial treatment of venous thromboembolism.

References

  1. N Engl J Med. 1996 Mar 14;334(11):682-7 - PubMed
  2. Thromb Haemost. 1994 Aug;72 (2):186-90 - PubMed
  3. N Engl J Med. 1986 Oct 30;315(18):1109-14 - PubMed
  4. Ann Intern Med. 1993 Nov 1;119(9):874-81 - PubMed
  5. N Engl J Med. 1996 Mar 14;334(11):677-81 - PubMed
  6. Chest. 1995 Oct;108(4 Suppl):335S-351S - PubMed
  7. Chest. 1995 Oct;108(4 Suppl):258S-275S - PubMed
  8. Arch Intern Med. 1993 Jul 12;153(13):1541-6 - PubMed
  9. N Engl J Med. 1992 Nov 19;327(21):1485-9 - PubMed
  10. Lancet. 1992 Feb 22;339(8791):441-5 - PubMed
  11. N Engl J Med. 1992 Apr 9;326(15):975-82 - PubMed

Publication Types